Skip to main content
Equibles
DRIO logo

DRIO · DarioHealth Corp. · Webcasts, Transcripts & Audio

Track DRIO — free

Use DRIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DRIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.02 +0.22 (+3.79%) At close · Oct 6
Rebalance outlook locked
Going-concern doubt — cleared Aug 11, 2026

The latest filing no longer states the doubt (first flagged May 13, 2026).

View the 10-Q filed Aug 11, 2026
Market Cap
$61.64M
Shares
9.80M
Volume · Oct 6 7754 Avg daily vol (3M) 24.58K

DarioHealth Corp. Webcasts

Earnings calls, investor updates, investor days and conferences for DarioHealth Corp. (DRIO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲17.5% $6.18M −$18.03M '22 Q2 22-08-15 ▲17.3% $6.61M −$15.63M '22 Q3 22-09-30 ▲13% $6.81M −$12.62M '22 Q4 23-02-06 ▼12.3% $7.07M −$12.82M '23 Q1 23-03-31 ▼0.5% $6.15M −$16.59M '23 Q2 23-07-24 ▼46.7% $3.52M −$15.73M '23 Q3 23-09-30 ▼46.9% $3.62M −$14.29M '23 Q4 23-12-31 ▼18.5% $5.76M −$7.17M '24 Q1 24-03-31 ▲1.7% $6.25M −$13.61M '24 Q2 24-06-30 ▲111% $7.42M −$12.33M '24 Q3 24-09-30 ▲110.3% $7.60M −$9.63M '24 Q4 24-12-31 ▲17.3% $6.75M −$9.23M '25 Q1 25-03-31 ▼14.2% $5.37M −$12.99M '25 Q2 25-06-30 ▼32.5% $5.01M −$10.47M '25 Q3 25-09-30 ▼31.2% $5.23M −$9.03M '25 Q4 25-12-31 LATEST ▼17.3% $5.58M −$8.25M '26 Q1 26-03-31
Earnings call
FY26 · Q1
2026-03-31
DarioHealth Corp. (DRIO) Q1 2026 Earnings Call Transcript
Confident tone Channel partnerships and covered lives expansion Evolution into care delivery / outcomes-based models Pipeline and health system / health plan opportunities
Revenue
$5.58M
▼ 17.3% YoY
Diluted EPS
$1.25
▼ 56.4% YoY
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
DarioHealth Corp. (DRIO) Q4 2025 Earnings Call Transcript
Revenue
$5.23M*
▼ 31.2% YoY
Gross margin
53.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
DarioHealth Corp. (DRIO) Q3 2025 Earnings Call Transcript
Confident tone Channel partners and covered lives New client wins and pipeline Revenue growth and multi-condition platform
Revenue
$5.01M
▼ 32.5% YoY
Diluted EPS
$2.96
▼ 39.7% YoY
Gross margin
60.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
DarioHealth Corp. (DRIO) Q2 2025 Earnings Call Transcript
Positive tone Multi-condition platform and GLP-1 strategy Claims-based billing expansion Margin improvement and cost reduction
Revenue
$5.37M
▼ 14.2% YoY
Diluted EPS
$3.54
▲ 121.2% YoY
Gross margin
55.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
DarioHealth Corp. (DRIO) Q1 2025 Earnings Call Transcript
Positive tone Twill Acquisition Integration AI Strategy Pharma Partnerships
Revenue
$6.75M
▲ 17.3% YoY
Diluted EPS
$2.87
▼ 28.2% YoY
Gross margin
57.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
DarioHealth Corp. (DRIO) Q4 2024 Earnings Call Transcript
Confident tone Multi-condition / whole-person care GLP-1 companion solutions Revenue and gross margin performance
Revenue
$7.60M*
▲ 110.3% YoY
Gross margin
55.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
Confident tone Revenue growth and B2B2C channel Operating expense reduction and path to profitability Twill integration and restructuring
Revenue
$7.42M
▲ 111% YoY
Diluted EPS
$4.91
▼ 49.9% YoY
Gross margin
52.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
DarioHealth Corp. (DRIO) Q2 2024 Earnings Call Transcript
Positive tone B2B2C channel growth Pharma channel transition and price concession Twill acquisition integration and cross-selling
Revenue
$6.25M
▲ 1.7% YoY
Diluted EPS
$1.60
▼ 86.2% YoY
Gross margin
44.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
DarioHealth Corp. (DRIO) Q1 2024 Earnings Call Transcript
Confident tone Twill acquisition synergies Major customer relationships B2B2C recurring revenue channel
Revenue
$5.76M
▼ 18.5% YoY
Diluted EPS
$4.00
▼ 55.6% YoY
Gross margin
42.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
DarioHealth Corp. (DRIO) Q4 2023 Earnings Call Transcript
Revenue
$3.62M*
▼ 46.9% YoY
Gross margin
3.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
DarioHealth Corp. (DRIO) Q3 2023 Earnings Call Transcript
Revenue
$3.52M
▼ 46.7% YoY
Diluted EPS
$9.80
▼ 23.4% YoY
Gross margin
17.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-24
DarioHealth Corp. (DRIO) Q2 2023 Earnings Call Transcript
Revenue
$6.15M
▼ 0.5% YoY
Diluted EPS
$11.60
▼ 21.6% YoY
Gross margin
33.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
DarioHealth Corp. (DRIO) Q1 2023 Earnings Call Transcript
Revenue
$7.07M
▼ 12.3% YoY
Diluted EPS
$9.00
▼ 39.2% YoY
Gross margin
44.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-06
DarioHealth Corp. (DRIO) Q4 2022 Earnings Call Transcript
Revenue
$6.81M*
▲ 13% YoY
Gross margin
40.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
DarioHealth Corp. (DRIO) Q3 2022 Earnings Call Transcript
Revenue
$6.61M
▲ 17.3% YoY
Diluted EPS
$12.80
▼ 45.8% YoY
Gross margin
27.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
DarioHealth Corp. (DRIO) Q2 2022 Earnings Call Transcript
Revenue
$6.18M
▲ 17.5% YoY
Diluted EPS
$14.80
▼ 25.3% YoY
Gross margin
18.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
DarioHealth Corp. (DRIO) Q1 2022 Earnings Call Transcript
Revenue
$8.06M
▲ 124.2% YoY
Diluted EPS
$14.80
▼ 19.6% YoY
Gross margin
49.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-19
DarioHealth Corp. (DRIO) Q4 2021 Earnings Call Transcript
Revenue
$6.03M*
▲ 189.8% YoY
Gross margin
9.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
DarioHealth Corp. (DRIO) Q3 2021 Earnings Call Transcript
Revenue
$5.63M
▲ 175.7% YoY
Diluted EPS
$23.60
Gross margin
14.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
DarioHealth Corp. (DRIO) Q2 2021 Earnings Call Transcript
Revenue
$5.26M
▲ 194.4% YoY
Diluted EPS
$19.80
Gross margin
28.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
DarioHealth Corp. (DRIO) Q1 2021 Earnings Call Transcript
Revenue
$3.60M
▲ 115.7% YoY
Diluted EPS
$18.40
Gross margin
30.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
DarioHealth Corp. (DRIO) Q4 2020 Earnings Call Transcript
Revenue
$2.08M*
▲ 15.7% YoY
Gross margin
26.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
DarioHealth Corp. (DRIO) Q3 2020 Earnings Call Transcript
Revenue
$2.04M
▲ 9.3% YoY
Diluted EPS
$-14.20
Gross margin
26.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
DarioHealth Corp. (DRIO) Q2 2020 Earnings Call Transcript
Revenue
$1.79M
▲ 8.2% YoY
Diluted EPS
$-13.60
Gross margin
35.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
DarioHealth Corp. (DRIO) Q1 2020 Earnings Call Transcript
Revenue
$1.67M
▼ 25.6% YoY
Gross margin
46.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 webcasts
Key facts CIK 1533998 CUSIP 23725P308 Visit website Investor relations